Stockscreener 앱 받기
12.53
2.19%
-0.28
시간 외 거래:
12.55
0.02
+0.16%
전일 마감가:
$12.81
열려 있는:
$12.75
하루 거래량:
278.00K
Relative Volume:
0.60
시가총액:
$432.56M
수익:
$90.44M
순이익/손실:
$561.00K
주가수익비율:
2,088.33
EPS:
0.006
순현금흐름:
$19.19M
1주 성능:
-4.93%
1개월 성능:
+8.86%
6개월 성능:
+14.12%
1년 성능:
+13.09%
1일 변동 폭
$12.43
$12.86
1주일 범위
$12.32
$13.27
52주 변동 폭
$8.12
$13.74
Delcath Systems Inc Stock (DCTH) Company Profile
명칭
Delcath Systems Inc
전화
(518) 743-8892
주소
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
12.53 | 442.22M | 90.44M | 561.00K | 19.19M | 0.006 |
ABT
Abbott Laboratories
|
100.57 | 173.61B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
309.24 | 120.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
81.89 | 105.41B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
42.97 | 64.20B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
84.37 | 48.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Craig Hallum | Buy |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2022-07-26 | 재개 | Canaccord Genuity | Buy |
| 2021-12-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-09 | 개시 | Canaccord Genuity | Buy |
| 2021-01-05 | 개시 | BTIG Research | Buy |
| 2020-06-01 | 개시 | Laidlaw | Buy |
모두보기
Delcath Systems Inc 주식(DCTH)의 최신 뉴스
Delcath Systems announces inducement grants - Medical Buyer
ETFs Investing in Delcath Systems, Inc. Stocks - TradingView
Four Delcath Employees Receive Stock Awards Tied to Vesting Dates - Stock Titan
Understanding Momentum Shifts in (DCTH) - Stock Traders Daily
Delcath Systems (DCTH) Slides 3.77% as Stock Tests Key Support LevelsFlat Correction - dars.gov.et
Is Delcath Systems Inc (DCTH) a Bargain After 3.8% Drop? GF Value Says Undervalued - GuruFocus
CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21 - Moomoo
Delcath Systems begins Phase 2 breast cancer trial - grafa.com
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer - BioSpace
Delcath doses first patient in breast cancer trial in Milan By Investing.com - Investing.com Nigeria
Delcath doses first patient in breast cancer trial in Milan - Investing.com
$13.513 | Delcath Systems, Inc. Common Stock (DCTH) Stock Price Today - Binance
Delcath Systems (DCTH) Gains 2.12% as Stock Approaches Key Resistance LevelGEX Level - DonanımHaber
DCTH Q1 2026 Earnings: EPS Surprises to the Upside as Company Advances Core PipelineEarnings Per Share - dars.gov.et
DCTHDelcath Systems Inc Options - Finviz
Price to sales forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView
Avoiding Lag: Real-Time Signals in (DCTH) Movement - Stock Traders Daily
Delcath Systems, Inc.(NasdaqCM:DCTH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Value Benchmark - marketscreener.com
Price to book forward of Delcath Systems, Inc. – SWB:DV3R - TradingView
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Value-Defensive Index - marketscreener.com
Price to earnings forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView
Enterprise value to revenue forward of Delcath Systems, Inc. – SWB:DV3R - TradingView
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 3000 Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView
Mettler-Toledo (MTD) soars 3.3%: Is further upside left in the stock? - MSN
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Defensive Index - marketscreener.com
Delcath Systems, Inc. Actuals & Estimates (FWB:DV3R) - TradingView
Delcath Systems, Inc. Actuals & Estimates (NASDAQ:DCTH) - TradingView
Delcath Systems, Inc. Actuals & Estimates (LS:A2PT5P) - TradingView
DCTH Forecast — Price Target — Prediction for 2027 - TradingView
Delcath Systems Inc (DCTH) Institutional Confidence - TradingKey
Delcath Systems (DCTH) Surges 5.6% on Above-Average Volume, Tests Key ResistanceChart Pattern Alerts - dars.gov.et
Delcath Systems, Inc. (DCTH) reports Q1 loss, misses revenue estimates - MSN
Delcath Systems Inc (DCTH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Delcath Systems (DCTH) Dips 2% as Stock Approaches Critical SupportHigh Volume Stocks - dars.gov.et
Delcath Systems Inc (DCTH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Delcath Systems Inc (DCTH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Delcath Systems Inc (DCTH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Delcath Systems Inc (DCTH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Delcath Systems Inc (DCTH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Delcath Systems Inc (DCTH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Delcath Systems (DCTH) Rallies 3.7%—Testing Key Resistance at $12.57Covered Call Trade - dars.gov.et
Q1 2026 Delcath Systems Inc Earnings Call Transcript - GuruFocus
Delcath Systems Inc (DCTH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Delcath Systems (DCTH) Q1 2026 Earnings: Narrower-than-Expected Losses Amid Clinical ProgressEarnings Season Preview - dars.gov.et
Delcath Systems (DCTH) Slips 1.5% as Shares Test Critical Support Near $11NHNL Ratio - DonanımHaber
Delcath Systems, Inc. - MLQ.ai
Delcath Systems, Inc. Stock 12‑Month Price Target Cut to $20.83, Implies 95% Upside - TradingView
European cancer guidelines add Delcath liver therapy for eye melanoma - Stock Titan
Delcath therapy included in European uveal melanoma guidelines - Investing.com
Delcath Systems Inc (DCTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
자본화:
|
볼륨(24시간):